Organic cation transporters (OCTs) are members of the solute carrier 22 (SLC22) family of transporter proteins that involved in absorption, distribution, and excretion of organic cations.
Introduction
The intestine plays a critical role in the absorption of nutrients and drugs. The intestinal epithelial cells (enterocytes) are polarized by the presence of tight junctions, and form a monolayer with the apical (AP) membrane facing the luminal side and the basolateral (BL) membrane facing the serosal side. Intestinal epithelium is the major barrier in the intestine, which controls the absorption of nutrients and drugs. Lipophilic compounds can cross this barrier by passive diffusion across AP and BL membranes of epithelial cells. However, hydrophilic and charged compounds can cross the epithelial barrier either via a paracellular route, which is highly inefficient, or transcellularly with the assistance of one or more transporters that are present in epithelial cell membranes.
Epithelial cells in the intestine, liver and kidney have specific transporters localized in either AP or BL membrane to facilitate directional transport of compounds and ensure their absorption by the intestine and excretion by the kidney and/or liver. Organic cation transporters (OCTs) belong to the solute carrier family 22 (SLC22) of polyspecific transporter proteins that are expressed in the liver, kidney, intestine, and other organs, transporting organic cationic compounds such as nutrients, endogenous amines, and many cationic drugs. OCTs are expressed as three different isoforms, namely OCT1, 2, and 3, and exhibit organ-specific distribution. Like other transporters, OCTs are expressed in specific cell membranes in epithelial tissues. For example, it is well established that OCTs, such as OCT1 and 3 are localized in the sinusoidal (BL) membrane of human hepatocytes, and are responsible for the uptake of cations from blood into the hepatocytes (Chen et al., 2010; Faber et al., 2003; Nies et al., 2009) ; similarly in the kidney, OCT2 is localized in the BL membrane of human renal proximal tubules and is responsible for the uptake of cations from the blood (Karbach et al., 2000; Motohashi et al., This article has not been copyedited and formatted. The final version may differ from this version. 2002; Okuda et al., 1996) . In the intestine, OCT3 is expressed in the AP membrane of enterocytes, and mediates the uptake of cations from the lumen into the enterocytes (Koepsell et al., 2007; Muller et al., 2005) . However, OCT1, which belongs to the same family of transporters as OCT3, has been reported to be localized in the BL membrane (Giacomini et al., 2010; Jonker et al., 2001; Koepsell et al., 2007; Muller et al., 2005; Wang et al., 2002; Watanabe et al., 2002a; Watanabe et al., 2002b) . This is surprising considering that other members of the OCT family, when expressed in the intestinal epithelium, are expressed in the AP membrane. It can be argued that OCT1 is expressed in the BL membrane to take up circulating organic cations into enterocytes; however, the affinities of OCTs for most substrates are low (e.g. apparent K m values >500μM) (Koepsell et al., 2007) and hence very high expression of the transporter would be needed to play a role in the serosal uptake and intestinal excretion of circulating organic cations.
Previous functional studies in our laboratory suggested that OCT1 is not localized in the BL membrane of Caco-2 cell monolayers. The organic cation drug ranitidine, which is a substrate for OCTs, showed saturable AP uptake into Caco-2 cell monolayers with egress across the BL membrane via passive diffusion processes (Bourdet et al., 2006; Bourdet et al., 2005) . BL uptake of ranitidine was mediated by a transporter with a very high apparent K m value of 67 mM (Lee et al., 2002) ; this kinetic behavior is not consistent with the presence of OCT1 in the BL membrane of Caco-2 cell monolayers. Another organic cation drug metformin, also a substrate for OCTs (Kimura et al., 2005) , showed saturable AP uptake and non-saturable inefficient BL uptake into Caco-2 cell monolayers (Proctor et al., 2008) . These data suggest, but do not provide definitive evidence that OCT1 is apically localized in Caco-2 cell monolayers; however, the results seem to rule out BL localization of the transporter in this cell model. This article has not been copyedited and formatted. The final version may differ from this version. Preliminary immunolocalization studies in Caco-2 cell monolayers suggested that OCT1 was localized in the AP membrane (Supplementary Figure 1) (Ng, 2002) . The present study was conducted to investigate the cellular localization of OCT1 in Caco-2 cell monolayers as well as in the mouse and human intestinal epithelia so as to resolve the contradiction between ambiguous reports in the literature suggesting BL localization of this transporter and the preliminary findings in our laboratory suggesting AP localization of OCT1 in Caco-2 cell monolayers.
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Caco-2 Cell Culture
Caco-2 cells were cultured as described previously (Proctor et al., 2008) . Briefly, the cells (passage numbers 30 to 40) were seeded at a density of 60,000 cells/cm 2 on polycarbonate membranes of Transwells™. The culture medium was changed the day following seeding and every other day thereafter. Cell monolayers with transepithelial electrical resistance greater than 300 Ω·cm 2 were used for experimentation at 21-28 days post seeding.
Generation of OCT1-Knockdown Caco-2 Clones
Three OCT1-specific small interfering RNA (siRNA) sequences (Sigma) were evaluated for their ability to silence OCT1 gene expression. Sequence 1 (sense strand: 5'-GCUAUGAAGUGGACUGGAA-3'; antisense strand: 5'-UUCCAGUCCACUUCAUAGC-3') and Sequence 3 (sense strand: 5'-CCAUCUGUGUGGGCAUCGU-3'; antisense strand: 5'-ACGAUGCCCACACAGAUGG-3') had the highest gene silencing activity (data not shown). 
Functional Uptake Studies
In Caco-2 cell monolayers, initial AP and BL uptake of This article has not been copyedited and formatted. The final version may differ from this version. 
Western Blot Analysis
The specificity of the primary rabbit anti-human OCT1 antibody was confirmed by
Western blot analysis. Chinese Hamster Ovary (CHO) cells were cultured as described previously (Ming et al., 2009 To demonstrate co-localization of OCT1(mOct1) with villin in Caco-2 cells and intestinal tissues, rabbit anti-human OCT1 and goat anti-human villin primary antibodies were applied together for 1h at RT, washed, and Alexa Fluor 568-goat anti-rabbit IgG and Alexa Fluor-488 donkey anti-goat IgG secondary antibodies were applied together to the cells or tissue slides.
After washing, mounting medium with DAPI was applied and confocal images were obtained with a Leica SP2 AOBS laser scanning confocal microscope.
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(unpublished data)) (Costales et al., 2011), or the pan inhibitor quinidine, whereas these inhibitors inhibited pentamidine uptake across the AP membrane by ~50% (Figure 1 C-D) .
These data imply that functionally active OCT1 localizes in the AP membrane of Caco-2 cell monolayers, and human and mouse intestinal tissues, and is absent in the BL membrane.
AP and BL Uptake of Pentamidine in OCT1 Knockdown Caco-2 Clones
To confirm results from chemical inhibition studies which provided evidence for functional localization of OCT1 in Caco-2 cells monolayers, pentamidine uptake was evaluated in Caco-2 cell monolayers in which OCT1 expression was down-regulated by OCT1-specific shRNA.
Three clones in which OCT1 expression was reduced by 70% or more were selected for experimentation (Figure 2 A) . Uptake of pentamidine across the AP membrane was decreased by 50% in OCT1-knockdown clones compared to control Caco-2 cell monolayers (Figure 2 in Caco-2 cell monolayers is not localized in the BL membrane, but is present in the AP membrane.
Specificity of the Rabbit Anti-human OCT1 Antibody for OCT1 and mOct1
In order to use the rabbit anti-human OCT1 antibody to assess the cellular localization of OCT1 and mOct1, it was important to demonstrate by Western blot analysis that the antibody detects OCT1 and does not cross-react with OCT2 or OCT3, but does cross-react with mOct1. liver, mouse liver and mouse kidney were probed with the rabbit anti-human OCT1 antibody.
The antibody specifically bound to a ~60 kDa protein, which is the expected size of OCT1 (mOct1), in the protein extracts of the OCT1-CHO cells, mOct1-CHO cell, wild-type Caco-2 cell, human and mouse liver homogenates (positive controls). In contrast, the antibody either did not yield a band or yielded a faint band with the protein extracts of the OCT2-3 CHO cells, mOct2-3 CHO cells, CHO K1 cells, OCT1 knockdown Caco-2 cells and mouse kidney (negative control) (Figure 3 ). These results confirm that the rabbit anti-human OCT1 antibody detects OCT1 and mOct1 without producing a false-positive signal with OCT2-3 (mOct 2-3).
Immunolocalization of OCT1 by Confocal Imaging in Caco-2 Cells, and Human and Mouse

Intestinal Tissues
Immunostaining and confocal microscopy studies in Caco-2 cell monolayers revealed that OCT1 is localized in the AP membrane (Figure 4 A) . The efflux transporter, P-gp, which is known to be exclusively localized in the AP membrane of Caco-2 cells, was found to be localized in the same membrane as OCT1 (Figure 4 
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another apically localized protein, villin, was investigated by immunostaining and confocal microscopy ( Figure 5 ). When images of antibody-labeled OCT1 (mOct1) (red fluorescence) and villin (green fluorescence) were merged, co-localization of these two proteins in Caco-2 cell as well as in human and mouse intestinal tissues was evidenced by a yellow color, thus unequivocally confirming the AP localization of OCT1 (mOct1).
Discussion
The results presented here contradict several reports which concluded that OCT1 (mOct1) is localized in the BL membrane of Caco-2 cell monolayers and enterocytes. The first suggestion that OCT1 (mOct1) (2002) showed that the amount of metformin associated with the duodenum, jejunum, and ileum was 3-to 7-fold higher in wild type mice than in mOct1 (-/-) mice. The authors interpreted these results to be suggestive of the presence of mOct1 in the BL membrane of the intestinal epithelium since this membrane faces the serosal blood capillaries. However, they appropriately indicated that this hypothesis should be tested with further experiments. Using functional studies of sulpiride uptake, Watanabe et al.
suggested that OCT1 is localized at the BL membrane of Caco-2 cells (Watanabe et al., 2002a; Watanabe et al., 2002b) . Subsequently, in Caco-2 cell monolayers that are widely used to study intestinal drug absorption and that exhibit low but detectable levels of OCT1 mRNA (Englund et This article has not been copyedited and formatted. The final version may differ from this version. 
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Caco-2 cells, 9-OCT1-knockdown Caco-2 cells, 10-human liver homogenate, 11-mouse liver homogenate, 12-mouse kidney homogenate. Anti-human OCT1 antibody specifically bound to a protein with an apparent molecular mass of ~60 kDa as shown. GAPDH was used as loading control. Gene expression studies showed high expression of mOct1 in the mouse liver tissue and low expression in the mouse kidney tissue (data in Supplementary Figure 2) . 
Methods
Laser Scanning Confocal Microscopy. Caco-2 cells grown on Transwells TM for 21-28 days were preincubated in HBSS at room temperature for 30 min, fixed for 10 min with either ice-cold acetone or phosphate buffered saline (PBS) with 1.85% formaldehyde, and then permeabilized for 10 min in 0.1% Triton X-100 in PBS. The cells were blocked for 30 min with PBS plus 2% normal goat serum (NGS) followed by incubation with rabbit anti-rat Oct1 or rabbit anti human P-gp antibodies (1:75) for 2 h. Primary antibodies were validated for cross-reactivity and specificity before experimentation. The filters were rinsed 3X in PBS and then incubated with the secondary antibody (Alexa Fluor 568-conjugated goat anti-rabbit IgG for OCT1 or Alexa Fluor 488-conjugated goat anti-rabbit IgG for P-gp) for 2 h. Filters were rinsed 3X in PBS, and the preparations were counterstained with either 0.5 µM SYSTOX green for 15 min or 0.5 µM propidium
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iodide in PBS for 1 min. All steps were performed at room temperature. After washing in PBS, filters were mounted on coverslips and confocal images were obtained with a Leica LSM laser scanning confocal microscope. Fluorophores were excited using an argon laser line at 488 nm and a HeNe laser line at 543 nm (Ng, 2002) .
Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Liver and kidney
homogenates from a C57BL/6 mouse were used to study the mRNA expressions of mOct1-3 relative to 18s rRNA (18s). qRT-PCR experiments were conducted using the same procedures as described in the Method section. 
Supplementary Figure Legend
